Trefoil peptides: From structure to function

Cellular and Molecular Life Sciences

Volumn 53, Issue 11-12, 1997, Pages 888-903

  Thim, L ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Epithelial restitution; Inflammatory bowel disease; Intestinal trefoil factor; pS2; Spasmolytic polypeptide; TFF domain; Trefoil factors; Ulcer

Indexed keywords

CYSTEINE; TREFOIL PEPTIDE;

DISULFIDE BOND; HUMAN; MAMMAL; NONHUMAN; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION;

LOTUS; MAMMALIA;

EID: 0031449635     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050108     Document Type: Review

References (172)

1. Thim L. (1989) A new family of growth factor-like peptides: 'trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP) and frog skin peptides (spasmolysins). FEBS Lett. 250: 85-90
2. Jørgensen K. H., Thim L. and Jacobsen H. E. (1981) Preparation and characterization of PSP, a new polypeptide from porcine pancreas. Diabetalogia 21: 288
3. Jørgensen K. H., Thim L. and Jacobsen H. E. (1982) Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul. Peptides 3: 207-219
4. Thim L., Jørgensen K. H. and Jørgensen K. D. (1982) Pancreatic spasmolytic polypeptide (PSP): II. Radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice. Regul. Peptides 3: 221-230
5. Jakowlew S. B., Breathnach R., Jeltsch J. M., Masiakowski P. and Chambon P. (1984) Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res. 12: 2861-2878
6. Prud'homme J. F., Fridlansky F., Le Cunff M., Atger M., Mercier-Bodart C., Pichon M. F. et al. (1985) Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA 4: 11-21
7. Suemori S., Lynch-Devaney K. and Podolsky D. K. (1991) Identification and characterization of rat intestinal trefoil factor: Tissue- and cell-specific member of the trefoil protein family. Proc. Natl. Acad. Sci. USA 88: 11017-11021
8. Podolsky D. K., Lynch-Devaney K., Stow J. L., Oates P., Murgue B., Debeaumont M. et al. (1993) Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J. Biol. Chem. 268: 6694-6702
9. Tomasetto C., Rio M., Gautier C., Wolf C., Hareuveni M., Chambon P. et al. (1990) hSP, the domain-duplicated homolog of pS2 protein is co-expressed with pS2 in the stomach but not in breast carcinoma. EMBO J. 9: 407-414
10. Rio M. C., Bellocq J. P., Daniel J. Y., Tomasetto C., Lathe R., Chenard M. P. et al. (1988) Breast cancer-associated pS2 protein: Synthesis and secretion by normal stomach mucosa. Science 241: 705-708
11. Poulsom R. and Wright N. A. (1993) Trefoil peptides: a newly recognized family of epithelial mucin associated molecules. Am. J. Physiol. 265: G205-G213
12. Thim L. (1994) Trefoil peptides: a new family of gastrointestinal molecules. Digestion 55: 353-360
13. Hoffmann W. and Hauser F. (1993) The P-domain or trefoil motif: a role in renewal and pathology of mucous epithelia? Trends Biochem. Sci. 18: 239-243
14. Podolsky D. K. (1993) Regulation of intestinal epithelial proliferation: a few answers, many questions. Am. J. Physiol. 264: G179-G186
15. Otto B. and Wright N. (1994) Trefoil peptides coming up clover. Curr. Biol. 4: 835-838
16. Sands B. E. and Podolsky D. K. (1996) The trefoil peptide family. Ann. Rev. Physiol. 58: 253-273
17. Podolsky D. K. (1997) Healing the epithelium solving the problem from two sides. J. Gastroenterol. 32: 122-126
18. Göke M. and Podolsky D. K. (1996) Regulation of the mucosal epithelial barrier. Bail. Clin. Gastrol. 10: 393-405
19. Playford R. J. (1997) Trefoil peptides what are they and what do they do? J. R. Coll. Physicians Lond. 31: 37-41
20. Chinery R. and Coffey R. J. (1996) Trefoil peptides less clandestine in the intestine. Science 274: 204
21. Featherstone C. (1997) Soothing the troubled gut with trefoil factors. Lancet 349: 706
22. Rio M. C. (1997) Which function(s) for trefoil peptides? Bulletin du Cancer 84: 443-446
23. Jørgensen K. H., Jørgensen K. D. and Thim L. (1979) Spasmolytic polypeptide. UK Patent Application 2059970
24. Jørgensen K. H., Jørgensen K. D. and Thim L. (1980) Pancreatic spasmolytic polypeptide. US Patent Application 185,796
25. Jørgensen K. H., Jørgensen K. D. and Thim L. (1983) Pancreatic spasmolytic polypeptide. US Patent 4,370,317 (Filed 9 March, 1981)
26. Jørgensen K. D., Diamant B., Jørgensen K. H. and Thim L. (1982) Pancreatic spasmolytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul. Peptides 3: 231-243
27. Thim L., Jørgensen K. H., Thomsen J., Christensen M. and Jacobsen H. E. (1992) The amino acid sequence of pancreatic spasmolytic polypeptide. 4th International Symposium on Gastrointestinal Hormones, Stockholm, Sweden 20-23 June 1982 (Abstract)
28. Thim L., Thomsen J., Christensen M. and Jørgensen K. H. (1985) The amino acid sequence of pancreatic spasmolytic polypeptide. Biochim. Biophys. Acta 827: 410-418
29. Rose K., Savoy L. A., Thim L., Christensen M. and Jørgensen K. H. (1989) Revised amino acid sequence of pancreatic spasmolytic polypeptide exhibits greater similarity with an inducible pS2 peptide found in a human breast cancer cell line. Biochim. Biophys. Acta 998: 297-300
30. Masiakowski P., Breathnach R., Bloch J., Gannon F., Krust A. and Chambon P. (1982) Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10: 7895-7903
31. Thim L. (1988) A surprising sequence homology. Biochem. J. 253: 309
32. Baker M. E. (1988) Oestrogen-induced pS2 protein is similar to pancreatic spasmolytic polypeptide and the kringle domain. Biochem. J. 253: 307-309
33. Hoffmann W. (1988) A new repetitive protein from Xenopus laevis skin highly homologous to pancreatic spasmolytic polypeptide. J. Biol. Chem. 263: 7686-7690
34. Wright N. A., Hoffmann W., Otto W. R., Rio M.-C. and Thim L. (1997) Rolling in the clover: Trefoil factor family (TFF)-domain peptides, cell migration and cancer. FEBS Lett. 408: 121-123
35. Moisan J., Mattei M. and Mandel J. (1988) Chromosome localization and polymorphism of an oestrogen-inducible gene specifically expressed in some breast cancers. Hum. Genet. 79: 168-171
36. Theisinger B., Welter C., Seitz G., Rio M. C., Lathe R., Chambon P. et al. (1991) Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinomas. Eur. J. Cancer 27: 770-773
37. Tomasetto C., Rockel N., Mattei M. G., Fujita R. and Rio M. C. (1992) The gene encoding the human spasmolytic protein (SML1/hSP) is in 21q22.3, physically linked to the homologous breast cancer marker gene BCEI pS2. Genomics 13: 1328-1330
38. May F. E. B. and Westley B. R. (1997) Close physical linkage of the genes encoding the pnr-2 ps2 protein and human spasmolytic protein (hsp). Hum. Genet. 99: 303-307
39. Seib T., Dooley S. and Welter C. (1995) Characterization of the genomic structure and the promoter region of the human intestinal trefoil factor. Biochem. Biophys. Res. Commun. 214: 195-199
40. Chinery R., Williamson J. and Poulsom R. (1996) The gene encoding human intestinal trefoil factor (tff3) is located on chromosome 21q22.3 clustered with other members of the trefoil peptide family. Genomics 32: 281-284
41. Schmitt H., Wundrack I., Beck S., Gott P., Welter C., Shizuya H. et al. (1996) A third P-domain peptide gene (TFF3), human intestinal trefoil factor, maps to 21q22.3. Cytogenet. Cell Genet. 72: 299-302
42. Beck S., Schmitt M., Shizuya H., Blin N. and Gott P. (1996) Cloning of contiguous genomic fragments from human chromosome 21 harboring three trefoil peptide genes. Hum. Genet. 98: 233-235
43. Gött P., Beck S., Machado J. C., Carneiro F., Schmitt H. and Blin N. (1996) Human trefoil peptides genomic structure in 21q22.3 and coordinated expression. Eur. J. Hum. Genet. 4: 308-315
44. Seib T., Blin N., Hilgert K., Seifert M., Theisinger B., Engel M. et al. (1997) The three human trefoil genes tff1, tff2 and tff3 are located within a region of 55 kb on chromosome 21q22.3. Genomics 40: 200-202
45. Playford R. J., Marchbank T., Goodlad R. A., Chinery R. A., Poulsom R., Hanby A. M. et al. (1996) Transgenic mice that overexpress the human trefoil peptide ps2 have an increased resistance to intestinal damage. Proc. Natl. Acad. Sci. USA 93: 2137-2142
46. Lefebvre O., Chenard M. P., Masson R., Linares J., Dierich A., Lemeur M. et al. (1996) Gastric-mucosa abnormalities and tumorigenesis in mice lacking the ps2 trefoil protein. Science 274: 259-262
47. Mashimo H., Wu D. C., Podolsky D. K. and Fishman M. C. (1996) Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274: 262-265
48. Warne N. W. and Laskowski M. (1990) All fifteen possible arrangements of three disulphide bridges in proteins are known. Biochim. Biophys. Res. Commun 172: 1364-1370
49. Mori K., Fujii R., Kida N., Ohta M. and Hayashi K. (1988) Identification of a polypeptide secreted by human breast cancer cells (MCF-7) as the human estrogen-responsive gene (pS2) product. Biochem. Biophys. Res. Commun. 155: 366-372
50. Rio M. C., Lepage P., Diemunsch P., Roitsch C. and Chambon P. (1988) Primary structure of human protein pS2. CR. Acad. Sci. III 307: 825-831
51. Gajhede M., Petersen T. N., Henriksen A., Petersen J. F., Dauter Z., Wilson K. S. et al. (1993) Pancreatic spasmolytic polypeptide: First three-dimensional structure of a member of the mammalian trefoil family of peptides. Structure 1: 253-262
52. Carr M. D. (1992) 1H NMR-based determination of the secondary structure of porcine pancreatic spasmolytic polypeptide: One of a new family 'trefoil' motif containing cell growth factors. Biochemistry 31: 1998-2004
53. De A., Brown D. G., Gorman M. A., Carr M. D., Sanderson M. R. and Freemont P. S. (1994) Crystal structure of a disulphide-linked 'trefoil' motif found in a large family of putative growth factors. Proc. Natl. Acad. Sci. USA 91: 1084-1088
54. Carr M. D., Bauer C. J., Gradwell M. J. and Feeney J. (1994) Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic polypeptide. Proc. Natl. Acad. Sci. USA 91: 2206-2210
55. Chadwick M. P., May F. E. B. and Westley B. R. (1995) Production and comparison of mature single-domain trefoil peptides pNR-2 pS2 Cys(5S) and pNR-2 pS2 Ser(58). Biochem. J. 308: 1001-1007
56. Petersen T. N., Henriksen A. and Gajhede M. (1996) Structure of porcine spasmolytic polypeptide at 1.95 Å resolution. Acta Cryst. D52: 730-737
57. Polshakov V. I., Frenkiel T. A., Westley B., Chadwick M., May F., Carr M. D. and Feeney J. (1995) NMR-based structural studies of the pNR-2 pS2 single-domain trefoil peptide similarities to porcine spasmolytic peptide and evidence for a monomeric structure. Eur. J. Biochem. 233: 847-855
58. Magnusson S., Petersen T. E., Sottrup-Jensen L. and Claeys H. (1975) Complete primary structure of prothrombin. In: Proteases and biological control, pp. 123-149. Reich E., Rifkin D. B., Shaw E. (eds), Cold Spring Harbor, Cold Spring Harbor Laboratory
59. Gregory H. and Preson B. M. (1977) The primary structure of urogastrone. Int. J. Pept. Protein Res. 9: 107-118
60. Blundell T. L. and Humbel R. E. (1980) Hormone families: Pancreatic hormones and homologous growth factors. Nature 287: 781-787
61. Hauser F., Gertzen E. M. and Hoffmann W. (1990) Expression of spasmolysin (FIM-A, 1): an integumentary mucin from Xenopus laevis. Exp. Cell. Res. 189: 157-162
62. Hauser F. and Hoffmann W. (1991) xP1 and xP4. P-domain peptides expressed in Xenopus laevis stomach mucosa. J. Biol. Chem. 266: 21 306-21 309
63. Hauser F., Roeben C. and Hoffmann W. (1992) xP2. a new member of the P-domain peptide family of potential growth factors, is synthesized in Xenopus laevis skin. J. Biol. Chem. 267: 14451-14455
64. Gmachl M., Berger H., Thalhammer J. and Kreil G. (1990) Dermal glands of Xenopus laevis contain a polypeptide with a highly repetitive amino acid sequence. FEBS Lett. 260: 145-148
65. Bork P. (1993) A trefoil domain in the major rabbit zona pellucida protein. Protein Sci. 2: 669-670
66. Green F., Edwards Y., Hauri H. P., Povey S., Ho M. W., Pinto M. et al. (1987) Isolation of a cDNA probe for a human jejunal brush-border hydrolase, sucrase-isomaltase, and the assignment of the gene locus to chromosome 3. Gene 57: 101-110
67. Hoefsloot L. H., Hoogeveen-Westerveld M., Kroos M. A., vanBeeumen J., Reuser A. J. J. and Oostra B. A. (1988) Primary structure and processing of lysosomal alpha-glucosidase: Homology with intestinal sucrase-isomaltase complex. EMBO J. 7: 1697-1704
68. Poulsom R. (1996) Trefoil peptides. Bail. Clin. Gastrol. 10: 113-134
69. Hanby A. M., Poulsom R., Singh S., Elia G., Jeffery R. and Wright N. A. (1993) Spasmolytic polypeptide is a major antral peptide: Distribution of the trefoil peptide human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 105: 1110-1116
70. Sands B. E., Ogata H., Lynch-Devaney K., deBeaumont M., Ezzell R. M. and Podolsky D. K. (1995) Molecular cloning of the rat intestinal trefoil factor gene characterization of an intestinal goblet cell-associated promoter. J. Biol. Chem. 270: 9353-9361
71. Rasmussen T. N., Raaberg L., Poulsen S. S., Thim L. and Holst J. J. (1992) Immunohistochemical localization of pancreatic spasmolytic polypeptide (PSP) in the pig. Histochemistry 98: 113-119
72. Taupin D. R., Pang K. C., Green S. P. and Giraud A. S. (1995) The trefoil peptides spasmolytic polypeptide and intestinal trefoil factor are major secretory products of the rat gut. Peptides 16: 1001-1005
73. Jeffrey G. P., Oates P. S., Wang T. C., Babyatsky M. W. and Brand S. J. (1994) Spasmolytic polypeptide: a trefoil peptide secreted by rat gastric mucuos cells. Gastroenterology 106: 336-345
74. Lefebvre O., Wolf C., Kedinger M., Chenard M. P., Tomasetto C., Chamhon P. et al. (1993) The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. J. Cell Biol. 122: 191-198
75. Sarraf C. E., Alison M. R., Ansari T. W. and Wright N. A. (1995) Subcellular distribution of peptides associated with gastric mucosal healing and neoplasia. Microsc. Res. Tech. 31: 234-247
76. Hanby A. M., Poulsom R., Elia G., Singh S., Longcroft J. M. and Wright N. A. (1993) The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in 'gastric metaplasia' of the proximal duodenum: Implications for the nature of 'gastric metaplasia'. J. Pathol. 169: 355-360
77. Henry J. A., Bennett M. K., Piggott N. H., Levett D. L., May F. E. and Westley B. R. (1991) Expression of the pNR-2 pS2 protein in diverse human epithelial tumours. Br. J. Cancer 64: 677-682
78. Luqmani Y., Bennett C., Paterson I., Corbishley C. M., Rio M. C., Chambon P. et al. (1989) Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int. J. Cancer 44: 806-812
79. Machado J. C., Carneiro F., Blin N. and Sobrinhosimoes M. (1996) Pattern of pS2 protein expression in premalignant and malignant lesions of gastric-mucosa. Eur. J. Cancer Prev. 5: 169-179
80. Machado J. C., Carneiro F., Ribeiro P., Blin N. and Sobrinho-Simoes M. (1996) pS2 protein expression in gastric-carcinoma an immunohistochemical and immunoradiometric study. Eur. J. Cancer 32: 1585-1590
81. Takahashi H., Kida N., Fujii R., Tanaka K., Ohta M., Mori K. et al. (1990) Expression of the pS2 gene in human gastric cancer cells derived from poorly differentiated adenocarcinoma. FEBS Lett. 261: 283-286
82. Wundrack I., Mullenbach R., Welter C., Seitz G. and Blin N. (1994) PCR expression analysis of the estrogen-inducible gene BCEI in gastrointestinal and other human tumors. Disease Markers 12: 63-69
83. Taupin D., Ooi K., Yeomans N. and Giraud A. (1996) Conserved expression of intestinal trefoil factor in the human colonie adenoma-carcinoma sequence. Lab. Invest. 75: 25-32
84. Rio M. C., Chenard M. P., Wolf C., Marcellin L., Tomasetto C., Lathe R. et al. (1991) Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 100: 375-379
85. Poulsom R., Chinery R., Sarraf C., Lalani E. N., Stamp G., Elia G. et al. (1992) Trefoil peptide expression in intestinal adaptation and renewal. Scand. J. Gastroenterol. 27 (Suppl. 192): 17-28
86. Wright N. A., Poulsom R., Stamp G., Vannorden S., Sarraf C., Elia G. et al. (1993) Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 104: 12-20
87. Chinery R. and Playford R. J. (1995) Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin. Sci. 88: 401-403
88. Babyatsky M. W., deBeaumont M., Thim L. and Podolsky D. K. (1996) Oral trefoil peptides protect against ethanol-induced and indomethacin-induced gastric injury in rats. Gastroenterology 110: 489-497
89. Welter C., Theisinger B., Seitz G., Tomasetto C., Rio M. C., Chambon P. et al. (1992) Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab. Invest. 66: 187-192
90. Collier J. D., Bennett M. K., Bassendine M. F. and Lendrum R. (1995) Immunolocalization of ps2, a putative growth factor, in pancreatic carcinoma. J. Gastroenterol. Hepatol. 10: 396-400
91. Dante R., Ribieras S., Baldassini S., Martin V., Benzerara O., Bouteille C. et al. (1994) Expression of an estrogen-induced breast cancer-associated protein (ps2) in benign and malignant human ovarian cysts. Lab. Invest. 71: 188-192
92. Wysocki S. J., Hahnel F.., Masters A., Smith V., McCartney A. J. and Hahnel R. (1990) Detection of pS2 messenger RNA in gynecological cancers. Cancer Res. 50: 1800-1802
93. Torres C., Turner J., Wang H., Shahsafaei A. and Odze R. (1996) Trefoil peptide (ps2. hsp) expression in esophageal carcinomas. Lab. Invest. 74: 376
94. Seitz G., Theisinger B., Tomasetto G., Rio M. C., Chambon P., Blin N. et al. (1991) Breast cancer-associated protein pS2 expression in tumors of the biliary tract. Am. J. Gastrol. 86: 1491-1494
95. Brown A. M., Jeltsch J. M., Roberts M. and Chambon P. (1984) Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. Sci. USA 81: 6344-6348
96. Rio M. C., Bellocq J. P., Gairard B., Rasmussen U. B., Krust A., Koehl C. et al. (1987) Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc. Natl. Acad. Sci. USA 84: 9243-9247
97. Nunez A. M., Jakowlev S., Briand J. P., Gaire M. Krust A., Rio M. C. et al. (1987) Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7. Endocrinology 121: 1759-1765
98. Rio M. C. and Chambon P. (1990) The pS2 gene, mRNA and protein: A potential marker for breast cancer. Cancer Cells 2: 269-274
99. Henry J. A., Piggott N. H., Mallick U. K., Nicholson S., Farndon J. R., Westley B. R. et al. (1991) pNR-2 pS2 immunohistochemical staining in breast cancer. Br. J. Cancer 63: 615-622
100. Foekens J. A., van Putten W. L., Portengen H., de Koning H. Y., Thirion B., Alexieva-Figusch J. et al. (1993) Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. J. Clin. Oncol. 11: 899-908
101. Wilson Y. G., Rhodes M., Ibrahim N. B. N., Padfield C. J. H. and Cawthorn S. J. (1994) Immunocytochemical staining of pS2 protein in fine needle aspirate from breast cancer is an accurate guide to response to tamoxifen in patients aged over 70 years. Br. J. Surg. 81: 1155-1158
102. Theisinger B., Seitz G., Dooley S. and Welter C. (1996) A second trefoil protein, ITF hP1.B. is transcribed in human breast cancer. Breast Cancer Res. Treat. 38: 145-151
103. Hirota M., Awatsuji H., Sugihara Y., Miyashita S., Furukawa Y. and Hayashi K. (1995) Expression of pS2 gene in rat-brain. Biochem. Mol. Biol. 35: 1079-1084
104. Probst J. C., Zetzsche T., Weber M., Theilemann P., Skutella T., Landgraf R. et al. (1996) Human intestinal trefoil factor is expressed in human hypothalamus and pituitary evidence for a novel neuropeptide. FASEB J. 10: 1518-1523
105. Probst J. C., Skutella T., Mullerschmid A., Jirikowski G. F. and Hoffmann W. (1995) Molecular and cellular analysis of rP1.B in the rat hypothalamus in situ hybridization and immunohistochemistry of a new P-domain neuropeptide. Mol. Brain Res. 33: 269-276
106. Hauser F. and Hoffmann W. (1992) P-domains as shuffled cysteine-rich modules in integumentary mucin C. 1 (FIM-C, 1) from Xenopus laevis. Polydispersity and genetic polymorphism. J. Biol. Chem. 267: 24620-24624
107. Wright N. A., Poulsom R., Stamp G. W., Hall P. A., Jeffery R. E., Longcroft J. M. et al. (1990) Epidermal growth factor (EGF URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J. Pathol. 162: 279-284
108. Wright N. A., Pike C. and Elia G. (1990) Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 343: 82-85
109. Ahnen D. J., Poulsom R., Stamp G. W. H., Elia G., Pike C., Jeffery R. et al. (1994) The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentiation program but acquires the proliferative organization of the gastric gland. J. Pathol. 173: 317-326
110. Patel K., Hanby A. M., Ahnen D. J., Playford R. J. and Wright N. A. (1994) The kinetic organization of the ulcer-associated cell lineage (UACL) - delineation of a novel putative stem-cell region. Epithelial Cell Biology 3: 156-160
111. Hauser F., Poulsom R., Chinery R., Rogers L. A., Hanby A. M., Wright N. A. et al. (1993) hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc. Natl. Acad. Sci. USA 90: 6961-6965
112. Alison M. R., Chinery R., Poulsom R., Ashwood P., Longcroft J. M. and Wright N. A. (1995) Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor-alpha messenger-RNAs in rat stomach. J. Pathol. 175: 405-414
113. Playford R. J. (1995) Peptides and gastrointestinal mucosal integrity. Gut 37: 595-597
114. Hanby A. M., Poulsom R., Singh S., Jankowski J., Hopwood D., Elia G. et al. (1993) Hyperplastic polyps: a cell lineage which both synthesizes and secretes trefoil peptides and has phenotypic similarity with the ulcer associated cell lineage. Am. J. Pathol. 142: 663-668
115. Hanby A. M., Jankowski J. A. Z., Elia G., Poulsom R. and Wright N. A. (1994) Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in barrett's metaplasia and the native esophageal epithelium delineation of epithelial phenotype. J. Pathol. 173: 213-219
116. Khulusi S., Hanby A. M., Marrero J. M., Patel P., Mendall M. A., Badve S. et al. (1995) Expression of trefoil peptides ps2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers. Gut 37: 205-209
117. Luqmani Y. A., Ryall G., Shousa S. and Coombes R. C. (1992) An immunohistochemical survey of pS2 expression in human epithelial cancers. Int. J. Cancer 50: 302-304
118. Wright N. (1996) Growth factors in inflammatory bowel disease. Can. J. Gastroenterol. 10: 191-198
119. Poulsom R., Begos D. E. and Moduli I. M. (1996) Molecular aspects of restitution functions of trefoil peptides. Yale J. Biol. Med. 69: 137-146
120. Williams R., Lalani E. N. and Stamp G. W. H. (1994) Natural gastrointestinal ulcer healing mechanism. J. R. Soc. Med. 87: 649-651
121. Boyle W. J. and Brenner D. A. (1995) Molecular and cellular biology of the small intestine. Curr. Opin. Gastroenterol. 11: 121-127
122. Modlin I. M. and Hunt R. H. (1995) Critical reappraisal of mucosal repair mechanisms. Scand. J. Gastoenterol. 30: 28-31
123. Amiranoff B. (1996) ps2. the trefoil peptide protecting the damaged intestine. Médicine Sciences 12: 846-847
124. Amiranoff B. and Rio M. C. (1997) while the trefoil peptides protect the digestive mucosa, one of them suppresses gastric tumors in vivo demonstration. Médicine Sciences 13: 93-94
125. Kindon H., Pothoulakis C., Thim L., Lynch-Devaney K. and Podolsky D. K. (1995) Trefoil peptide protection of intestinal epithelial barrier function cooperative interaction with mucin glycoprotein. Gastroenterology 109: 516-523
126. Plaut A. G. (1997) Trefoil peptides in the defense of the gastrointestinal tract. N. Engl. J. Med. 336: 506-507
127. Gibson P. R., Anderson R. P., Mariadason J. M. and Wilson A. J. (1996) Protective role of the epithelium of the small intestine and colon. Inflammatory Bowel Diseases 2: 279-302
128. Rachmilewitz D. (1996) Trefoil peptides a novel modality to prevent gastric injury. Gastroenterology 110: 632-635
129. Licato L. L. and Brenner D. A. (1997) Molecular and cellular biology of the small-intestine. Curr. Opin. Gastroenterol. 13: 90-93
130. Dignass A., Lynch-Devaney K., Kindon H., Thim L. and Podolsky D. K. (1994) Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J. Clin. Invest. 94: 376-383
131. Playford R. J., Marchbank T., Chinery R., Evison R., Pignatelli M., Boulton R. A. et al. (1995) Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108: 108-116
132. Konturek P. C., Brzozowski I., Konturek S. J., Elia G., Wright N., Sliwowski Z. et al. (1997) Role of spasmolytic polypeptide in healing of stress-induced gastric lesions in rats. Regul. Peptides 68: 71-79
133. Chinery R., Palyford R., Poulsom R. and Cox H. M. (1995) Intestinal trefoil factor stimulates mucosal repair processes in vitro and in vivo. Gastroenterology 108: A70
134. Kato K., Chen M. C., Lehman F., Nguyen M., Nakajima N., Kuwayama H. et al. (1995) Trefoil peptides. IGI-1 and basic FGF stimulate restitution in primary cultures of canine oxyntic mucosal cells. Gastroenterology 108: A130
135. Tomasetto C., Wolf C., Rio M. C., Mehtali M., Lemeur M., Gerlinger P. et al. (1989) Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milk. Mol. Endocrinol. 3: 1579-1584
136. Goldenring J. R., Poulsom R., Ray G. S., Wright N., Meise K. S. and Coffey R. J. (1996) Expression of trefoil peptides in the gastric mucosa of transgenic mice overexpressing transforming growth factor alpha. Growth Factors 13: 111-119
137. Cook G. A., Yeomans N. D. and Giraud A. S. (1997) Temporal expression of trefoil peptides in the TGF-alpha knockout mouse alter gastric ulceration. Am. J. Physiol. 35: G1540-G1549
138. Polshakov V. I., Williams M. A., Gargaro A. R., Frenkiel T. A., Westley B. R., Chadwick M. P. et al. (1997) High-resolution solution structure of human pNR-2 pS2 a single trefoil motif protein. J. Mol. Biol. 267: 418-432
139. Williams R., Stamp G. W. H., Gilbert C., Pignatelli M. and Lalani E. N. (1996) pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel. J. Cell Sci. 109: 63-71
140. Thim L., Wöldike H. F., Nielsen P. F., Christensen M., Lynch-Devaney K. and Podolsky D. K. (1995) Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry 34: 4757-4764
141. Taupin D. R. and Giraud A. S. (1994) Distribution of the trefoil peptides spasmolytic polypeptide and intestinal trefoil factor in the rat gut. Gastroenterology 106: A635
142. Taupin D. R., Ooi K., Shulkes A. and Giraud A. S. (1994) Identification of human intestinal trefoil factor in the colonic adenoma-carcinoma sequence. Gastroenterology 106: A635
143. Chinery R., Bates P. A., De A. and Freemont P. S. (1995) Characterization of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers. FEBS Lett. 357: 50-54
144. Hoosein N. M., Thim L., Jørgensen K., H. and Brattain M. G. (1989) Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Lett. 247: 303-306
145. Liu D., Chinery R., Wilding J., Gullick W. J., Kmiot W. and Pignatelli M. (1996) Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor. J. Pathol 179: A10
146. Chinery R. and Cox H. M. (1995) Modulation of epidermal growth-factor effects on epithelial ion-transport by intestinal trefoil factor. Br. J. Pharmacol. 115: 77-80
147. Otto W. R., Rao J., Cox H. M., Kotzian E., Lee C. Y., Goodlad R. A. et al. (1996) Effects of pancreatic spasmolytic polypeptide (PSP) on epithelial cell function. Eur. J. Biochem. 235: 64-72
148. Turner G. A., Logan R. P. H., Chinery R., Cockayne A., Hawkey C. J. and Borriello S. P. (1996) Trefoil peptides are chemotaxins for helicobacter pylori. Gastroenterology 110: A1032
149. McKenzie C., Marchbank T., Playford R. J., Otto W., Thim L. and Parson M. E. (1997) Pancreatic spasmolytic polypeptide protects the gastric mucosa but does not inhibit acid secretion or motility. Am. J. Physiol. 273: G112-G117
150. Tanaka S., Podolsky D. K., Engel E., Guth P. H. and Kaunitz J. D. (1997) Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro. Am. J. Physiol. 35: G1473-G1480
151. Fandsen E. K. (1988) Receptor binding of pancreatic spasmolytic polypeptide in intestinal mucosal cells and membranes. Regul. Peptides 20: 45-52
152. Frandsen E. K., Jørgensen K. H. and Thim L. (1986) Receptor binding of pancreatic spasmolytic polypeptide (PSP) in rat intestinal mucosal cell membranes inhibits the adenylate cyclase activity. Regul. Peptides 16: 291-297
153. Chinery R. and Cox H. M. (1995) Immunoprecipitation and characterization of a binding-protein specific for the peptide. intestinal trefoil factor. Peptides 16: 749-755
154. Elia G., Chinery R., Hanby A. M., Poulsom R. and Wright N. A. (1994) The production and characterization of a new monoclonal antibody to the trefoil peptide human spasmolytic polypeptide. Histochem. J. 26: 644-647
155. Williams R., Elia G., Stamp G. W. H., Oates T., Wright N. A. and Lalani E. N. (1996) Characterization of monoclonal-antibodies raised to C-terminal peptides of pS2 a major trefoil peptide and molility factor expressed in adenocarcinomas and regions of mucosal injury. Hum. Pathol. 27: 1259-1266
156. Goussard J., Lechevrel C., Roussel G., Cren H., Bera O. and Sala M (1991) Immonoradiometric assay of pS2 protein in breast cancer cytosols. Clin. Chem. 37: 1759-1762
157. Miyashita S., Nomoto H., Konishi H. and Hayashi K. (1994) Estimation of pS2 protein level in human-body fluids by a sensitive two-site enzyme immunoassay. Clin. Chim. Acta 228: 71-81
158. Predine J., Spyratos F., Prud'homme J. F., Andrieu C., Hacene K., Brunet M. et al. (1992) Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors and normal breast tissues. Correlation with prognosis and adjuvant hormone therapy. Cancer 69: 2116-2123
159. Offner G. D., Nunes D. P., Troxler R. F. and Oppenheim F. G. (1997) Identification of the trefoil protein pS2 in human salivary glands. J. Dental Res. 76: 1154
160. Rasmussen T. N., Thim L., Raaberg L., Harling H. and Holst J. J. (1990) Pancreatic spasmolytic polypeptide, a potential growth factor for the intestine: Neural control and secretion. Digestion 46 (Suppl. 2): 226-231
161. Rasmussen T. N., Harling H., Thim L., Pierzynowsky S., Westrom B. R. and Holst J. J. (1993) Regulation of secretion of pancreatic spasmolytic polypeptide from porcine pancreas. Am. J. Physiol. 264: G22-G29
162. Gajhede M., Thim L., Jørgensen K. H. and Melberg S. G. (1992) Pancreatic spasmolytic polypeptide: Crystallization, circular dichroism analysis and preliminary X-ray diffraction studies. Proteins Struct. Funct. Genet. 13: 364-368
163. Gorman M. A., De A. and Freemont P. S. (1992) Crystallization and preliminary X-ray diffraction studies of pancreatic spasmolytic polypeptide. J. Mol. Biol. 228: 991-994
164. Mori K., Fujii R., Kida N., Takahashi H., Ohkubo S., Fujino M. et al. (1990) Complete primary structure of the human estrogen-responsive gene (pS2) product. J. Biochem. 107: 73-76
165. Thim L., Hansen M. T., Norrris K., Hoegh I., Boel E., Forstrom J. et al. (1986) Secretion and processing of insulin precursors in yeast. Proc. Natl. Acad. Sci. USA 83: 6766-6770
166. Thim L., Norris K., Norris F., Nielsen P. F., Bjoørn S. E., Christensen M. et al. (1993) Purification and characterization or the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast. FEBS Lett. 318: 345-352
167. Prud'homme J. F., Jolivet A., Pichon M. F., Savouret J. F. and Milgrom E. (1990) Monoclonal antibodies against native and denatured forms of estrogen-induced breast cancer protein (BCEI-pS2) obtained by expression in Escherichia coli. Cancer Res. 50: 2390-2396
168. Chinery R., Poulsom R., Elia G., Hanby A. M. and Wright N. A. (1993) Expression and purification of a trefoil peptide motif in a beta-galactosidase fusion protein and its use to search for trefoil binding sites. Eur. J. Biochem. 212: 557-563
169. Itoh H., Tomita M., Uchino H., Kobayashi T., Kataoka H., Sokiya R. et al. (1996) cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis. Biochem. J. 318: 939-944
170. Chinery R., Poulsom R., Rogers L. A., Jeffery R. E., Longcroft J. M., Hanby A. M. et al. (1992) Localization of intestinal trefoil-factor mRNA in rat stomach and intestine by hybridization in situ. Biochem. J. 285: 5-8
171. Mashimo H., Podolsky D. K. and Fishman M. C. (1995) Structure and expression of murine intestinal trefoil factor high evolutionary conservation and postnatal expression. Biochem. Biophys. Res. Commun. 210: 31-37
172. Tomita M., Itoh H., Ishikawa N., Higa A., Ide H., Murakumo Y. et al. (1995) Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell chances. Biochem J. 311: 293-297